2-71110081-C-CT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_032601.4(MCEE):c.419_420insA(p.Lys141GlufsTer7) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000931 in 1,611,984 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Consequence
MCEE
NM_032601.4 frameshift
NM_032601.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.23
Genes affected
MCEE (HGNC:16732): (methylmalonyl-CoA epimerase) The product of this gene catalyzes the interconversion of D- and L-methylmalonyl-CoA during the degradation of branched chain amino acids. odd chain-length fatty acids, and other metabolites. Mutations in this gene result in methylmalonyl-CoA epimerase deficiency, which is presented as mild to moderate methylmalonic aciduria. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCEE | NM_032601.4 | c.419_420insA | p.Lys141GlufsTer7 | frameshift_variant | 3/3 | ENST00000244217.6 | NP_115990.3 | |
MCEE | XM_005264613.3 | c.257_258insA | p.Lys87GlufsTer7 | frameshift_variant | 3/3 | XP_005264670.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCEE | ENST00000244217.6 | c.419_420insA | p.Lys141GlufsTer7 | frameshift_variant | 3/3 | 1 | NM_032601.4 | ENSP00000244217 | P1 | |
MCEE | ENST00000413592.5 | c.125_126insA | p.Lys43GlufsTer7 | frameshift_variant | 2/2 | 2 | ENSP00000391140 | |||
MCEE | ENST00000462609.2 | n.365_366insA | non_coding_transcript_exon_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151896Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
151896
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1460088Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726388
GnomAD4 exome
AF:
AC:
14
AN:
1460088
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
726388
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151896Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74190
GnomAD4 genome
AF:
AC:
1
AN:
151896
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 11, 2022 | Variant summary: MCEE c.419dupA (p.Lys141GlufsX7) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay. A truncating mutation located in close proximity to the current variant (p.Lys140Argfs*6) has been reported in HGMD in association with Parkinson disease, dementia, stroke and elevated levels of methylmalonic acid. While the current variant may not result in NMD, it alters several amino acids located in the Vicinal oxygen chelate (VOC) domain (Interpro). It is unclear what impact the variant will have on the function of this protein. The variant was absent in 250236 control chromosomes. To our knowledge, no occurrence of c.419dupA in individuals affected with Methylmalonic Acidemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS - possibly pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at